United Therapeutics Corp (NASDAQ:UTHR)
CAPS Rating:
A biotechnology company focused on the development and commercialization of innovative therapeutic products for patients with chronic and life-threatening cardiovascular, cancer and infectious diseases.
RSS Headlines
Fool UK
Recs
To be honest, this is a "gut feeling" pick, i feel that their is potential here to get back up to their 52 week high level.